We Serve

Pharma

Pharma launches in the precision medicine space depend on diagnostics infrastructure that gets built years before the first prescription. The CDx partner committed to, the lab capacity that will absorb the launch, the markets ready for the asset, the disease areas where the testing infrastructure can carry the strategy — these are decisions that lock in long before the commercial team is staffed, and they shape whether the asset reaches patients on the timeline the pipeline assumes.

What we do

Select Capabilities

All Capabilities

Patient / Diagnostic Journey Mapping

As the precision medicine technologies and treatments evolve, so does the patient journey. Understanding how your products and services fit into the patient journey, and the barriers or challenges you may face, is critical to realizing your market potential.

View

Biomarker and Diagnostics Strategy

This is where precision medicine starts – whether you’re trying to find the right tools to uncover new biomarkers, identify CDx partners, launch an IVD, or understand how your assay will fit into the clinical journey, DeciBio has you covered. Nobody knows biomarkers and CDx better than DeciBio.

View

Go-to-Market Strategy

It’s time to execute. Understanding your customers, competitors, channels, and messaging is just the first step. Going to market requires coordination and alignment across the organization, and an ivory-tower strategy won’t be enough - you need tactics.

View